BioNTech-Pfizer mRNA vaccine largely effective against UK variant, Sera from 40 patients show

(American Association for the Advancement of Science) In a study evaluating the BioNTech-Pfizer COVID-19 vaccine's ability to neutralize the B.1.1.7 ('UK') viral variant, researchers found no loss of immune protection compared to that against the original Wuhan reference strain.